Abstract
The first bacterial vaccines were Pasteur’s attenuated strains of Pasteurella multocida and Bacillus anthracis, but until recently there has been relatively little effort to develop or use such strains for protection of humans, with the conspicuous exception of strain BCG, for prevention of tuberculosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akiyama et al., 1964, The use of diffusion chambers in investigating the cellular nature of immunity in experimental typhoid and tuberculosis, Japan. J. Microbiol. 8:37–48.
Bacon, G.A., Burrows, T.W. and Yates, M., 1951, The effects of biochemical mutation on the virulence of Bacterium typhosum: The loss of virulence of certain mutants, Br. J. Exp. Pathol. 32:85–96.
Brown, A. et al., 1987, An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice, J. Infect. Dis. 155:86–92.
Charbit, A., Boulain, J.C., Ryter, A., and Hofnung, M., 1986, Probing the topology of a bacterial membrane protein by genetic insertion of a foreign epitope; expression at the cell surface, EMBO J. 5:3029–3037.
Charbit, A et al., 1988, Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: First immunization results, Ann. Inst. Pasteur Microbiol. 139:45–58.
Clements, T.D. et al., 1986, Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile E. coli enterotoxin, Infect. Immun. 53:685–692.
Cryz, S.J. et al., 1989, Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a, Infect. Immun. 57:3863–3868.
Curtiss, R., III. and Kelly, S.M., 1987, Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic, Infect. Immun. 55:3035–3043.
Edwards, M.F. and Stocker, B.A.D., 1988, Construction of ΔaroA hisΔpur strains of Salmonella typhi, J. Bacteriol. 170:3991–3995.
Fahey, K.J. and Cooper, G.N., 1970, Oral immunization in experimental Salmonellosis II. Characteristics of the immune response to temperature-sensitive mutants given by oral and parenteral routes, Infect. Immun. 2:183–191.
Fairweather, N.E. et al., 1990, Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier, Infect Immun. 58:1323–1326.
Germanier, R., 1970, Immunity in experimental Salmonellosis I. Protection induced by rough mutants of Salmonella typhimurium, Infect. Immun. 2:309–315.
Germanier, R. and Furer, E., 1971, Immunity in experimental Salmonellosis: II. Basis for the avirulence and protective capacity of galE mutants of Salmonella typhimurium, Infect. Immun. 4:663–673.
Germanier, R. and Furer, E., 1975, Isolation and chararcterization of gale mutant Ty21a of Salmonella typhi: A candidate strain for a live, oral typhoid vaccine, J. Infect Dis. 131:553–558.
Gilman, R.H. et al., 1977, Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a live oral vaccine, J. Infect. Dis. 136:717–723.
Herrington, D.A. et al., 1990, Studies in volunteers to evaluate Shigella vaccines: Further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease, Vaccine 8:353–357.
Hoiseth, S.K. and Stocker, B.A.D., 1981, Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines, Nature 291:238–239.
Hoiseth, S.K. and Stocker, B.A.D., 1985, Genes aroA and serC of Salmonella typhimurium constitute an Operon, J. Bacteriol 163:355–61.
Hone, D.M. et al., 1988, A galE via (Vi antigen-negative) mutant of Salmonella typhi strain Ty2 retains virulence in humans, Infect. Immun 56:1326–1333.
Jacob, C.O., Sela, M. and Arnon, R., 1983, Antibodies against synthetic peptides of the B subunit of cholera toxin: Cross reaction and neutralization of the toxin. Proc. Natl. Acad. Sci. USA 80:7611–7615.
Joys, T.M., 1985, The covalent structure of the phase-1 flagellar filament protein of Salmonella typhimurium and its comparison with other flagellins. J. Biol Chem. 260:15758–15761.
Levine, M.M. et al., 1976, Attenuated Streptomycin-dependent Salmonella typhi oral vaccine: Potential deleterious effects of lyophilization, J. Infect Dis. 133:424–429.
Levine, M.M. et al., 1987, Safety, infectivity, immunogenicity and in vivo stability of tuso attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in man, J. Clin. Invest. 79:888–902.
Levine, M.D. et al., 1990, New and improved vaccines against typhoid fever, 269–287, In “New Generation Vaccines,” edit. Woodrow, C. and Levine, M.M., Academic Press, London.
Linde, K., 1983, Stable high immunogenic mutants of Salmonella with two independent attenuating markers as potential live vaccine, Devel. Biol. Stand. 53:15–28.
Linde, K., Beev, J., and Bondarenki, V., 1990, Stable Salmonella live vaccine strains with two or more attenuating mutations and any desired level of attenuation, Vaccine 8:278–282.
Majarian, W.R., Kasper, SJ. and Brey, R.N., 1989, Expression of heterologous epitopes as recombinant flagella on the surface of attenuated Salmonella, in “Vaccines 89: Modern approaches to new vaccines including prevention of AIDS” (ed. RA. Lerner et al.), (p. 277–281) Cold Spring Harbor Laboratory, New York.
Maskell, D.J. et al., 1987, Salmonella typhimurium aroA mutants as carriers of the E. coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems, Microb. Pathog. 2:211–221.
McFarland, W.C. and Stocker, B.A.D., 1987, Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium, Microb. Pathog. 3:129–141.
Morris, J.A., Wray, C. and Sojka, W.J., 1976, The effect of T and B lymphocyte depletion on the protection of mice vaccinated with a galE mutant of Salmonella typhimurium, Brit. J. Exper. Path. 57:354–360.
Mukkur, T.K. et al., 1987, Protection against experimental salmonellosis in mice and sheep by immunization with aromatic-dependent Salmonella typhimurium,]. Med. Microbiol. 24:11–19.
Newton, S.M.C., Jacob, C.O. and Stocker, B.A.D., 1989, Immune response to cholera toxin epitope inserted in Salmonella flagellin, Science 244:70–72.
Newton, S.M.C., Manning, W.C, Hovi, M., and Stocker, B.A.D., 1990, Aromatic-dependent Salmonella with foreign epitope insert in flagellin as live vaccine. In “Vaccines 90: Modern Approaches to New Vaccines Including Prevention of AIDS”, (ed. F. Brown et al.), (pp. 439–445) Cold Spring Harbor Laboratory, New York.
Newton, S.M.C. et al., 1991, Expression and immunogenicity of a Streptococcal M protein epitope inserted in Salmonella flagellin, Infect. Immun. 59:2158–2165.
Nnalue, N.A. and Stocker, B.A.D., 1986, Some galE mutants of Salmonella choleraesuis retain virulence, Infect Immun. 54:635–640.
O’Callaghan, D. et al., 1988, Characterization of aromatic- and purine-dependent Salmonella typhimurium: Attenuation, persistence and ability to induce protective immunity in BALB/c mice, Infect Immun. 56:419–423.
Poirier, T.P., Kehoe, M.A., and Beachey, E.H., 1988, Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein, J. Exp. Med. 168:25–32.
Robbins, J.B. and Schneerson, R., 1990, Polysaccharide-protein conjugates: A new generation of vaccines, J. Infect. Dis. 161:821–832.
Robertsson, J.A. et al., 1983, Salmonella typhimurium infection in calves: Protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines, Infect Immun. 41:742–750.
Sigwart, D.F., Stocker, B.A.D. and Clements, J.D., 1989, Effect of a purA mutation on the efficacy of Salmonella live-vaccine vectors. Infect Immun. 57:1858–1861.
Smith, B.P. et al., 1984, Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves, Am. J. Vet. Res. 45:59–66.
Smith, H.W., 1965, The immunization of mice, calves and pigs against Salmonella dublin and Salmonella chloraesuis infections. J. Hyg. (Camb.) 63:117–135.
Stocker, B.A.D., 1988, Auxotrophic Salmonella typhi as live vaccine, Vaccine 6:141–145.
Tacket, C.O. et al, 1990, Safety, immunogenicity, and efficacy against cholera challenge of a typhoid-cholera hybrid derived from Salmonella typhi Ty21a, Infect Immun 58:1620–1627.
Tite et al., 1988, Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characterization and cross-reactivity of T cell responses, J. Immunol. 141:3980–3987.
Wahdan, M.H. et al., 1982, A controlled field trial of livem Salmonella typhi strain Ty21a oral vaccine against typhoid: Three year results, J. Infect. Dis. 145:292–295.
Wei, L.-N. and Joys, T.M., 1985, Covalent structure of three phase-1 flagellar filament proteins of Salmonella, J. Mol. Biol. 186:791–803.
Wu, J.Y. et al., 1989, Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by vaccine strain of Salmonella, Proc. Natl. Acad. Sci. USA 86:4726–4730.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag New York, Inc.
About this paper
Cite this paper
Stocker, B.A.D. (1992). Attenuated Salmonella sp. as Live Vaccines and as Presenters of Heterologous Antigens. In: Hook, M., Switalski, L. (eds) Microbial Adhesion and Invasion. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2924-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2924-7_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7721-7
Online ISBN: 978-1-4612-2924-7
eBook Packages: Springer Book Archive